Inching towards a targeted therapy for preeclampsia
- PMID: 20026761
- PMCID: PMC4040955
- DOI: 10.1161/HYPERTENSIONAHA.109.143933
Inching towards a targeted therapy for preeclampsia
Comment on
-
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.Hypertension. 2010 Feb;55(2):380-5. doi: 10.1161/HYPERTENSIONAHA.109.141937. Epub 2009 Dec 21. Hypertension. 2010. PMID: 20026764 Free PMC article.
References
-
- Maynard SE, Karumanchi SA, Thadhani R. Hypertension and Kidney Disease in Pregnancy. In: Brenner BM, editor. Brenner & Rector's The Kidney. 8th ed. Philadelphia Saunders (Elsevier); 2008. pp. 1567–1595.
-
- Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683. - PubMed
-
- Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658. - PMC - PubMed
-
- Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, Lam A, O'Young G, Sannajust F, Stathis P, Schreiner G, Karumanchi SA, Protter AA, Pollitt NS. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 2007;50:686–692. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
